We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3076
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$347M
| $1.56K | ﹤0.01% |
+304
| New | +$1.48K |
2025 Q2
0 quarters
|
|
3077
UL Solutions
ULS
$15B
| $1.53K | ﹤0.01% |
+21
| New | +$1.38K |
2025 Q2
0 quarters
|
|
3078
Universal Insurance Holdings
UVE
$1.3B
| $1.52K | ﹤0.01% |
55
| – | – |
2024 Q1
5 quarters
|
|
3079
State Street SPDR S&P Kensho New Economies Composite ETF
KOMP
$2.53B
| $1.52K | ﹤0.01% |
28
+5
| +22% | +$244 |
2021 Q1
17 quarters
|
|
3080
DELISTED
Integral Ad Science
IAS
| $1.52K | ﹤0.01% |
183
-383
| -68% | -$2.92K |
2022 Q3
11 quarters
|
|
3081
Aimco
AIV
$244M
| $1.51K | ﹤0.01% |
175
-254
| -59% | -$2.06K |
2016 Q4
34 quarters
|
|
3082
Newsmax Inc
NMAX
$1.2B
| $1.51K | ﹤0.01% |
+100
| New | +$2.62K |
2025 Q2
0 quarters
|
|
3083
Celldex Therapeutics
CLDX
$2.27B
| $1.51K | ﹤0.01% |
74
-859
| -92% | -$16.7K |
2022 Q2
12 quarters
|
|
3084
Camping World
CWH
$292M
| $1.5K | ﹤0.01% |
87
+82
| +1,640% | +$1.28K |
2020 Q2
20 quarters
|
|
3085
iRadimed
IRMD
$1.14B
| $1.5K | ﹤0.01% |
25
+16
| +178% | +$877 |
2024 Q2
4 quarters
|
|
3086
iShares New York Muni Bond ETF
NYF
$1.6B
| $1.49K | ﹤0.01% |
28
| – | – |
2023 Q3
7 quarters
|
|
3087
DELISTED
Soho House & Co
SHCO
| $1.48K | ﹤0.01% |
201
+1
| +0.5% | +$6 |
2024 Q3
3 quarters
|
|
3088
AGNT Inc
AGNT
$653M
| $1.47K | ﹤0.01% |
162
+128
| +376% | +$1.12K |
2021 Q3
15 quarters
|
|
3089
Riley Exploration Permian
REPX
$1.04B
| $1.47K | ﹤0.01% |
56
+45
| +409% | +$1.19K |
2024 Q3
3 quarters
|
|
|
PKST
3090
DELISTED
Peakstone Realty Trust
PKST
| $1.44K | ﹤0.01% |
109
-198
| -64% | -$2.43K |
2024 Q4
2 quarters
|
|
3091
Graham Corp
GHM
$835M
| $1.44K | ﹤0.01% |
+29
| New | +$1.07K |
2025 Q2
0 quarters
|
|
3092
Equity Bancshares
EQBK
$961M
| $1.43K | ﹤0.01% |
35
+18
| +106% | +$698 |
2023 Q1
9 quarters
|
|
3093
SelectQuote
SLQT
$60.9M
| $1.43K | ﹤0.01% |
600
| – | – |
2024 Q1
5 quarters
|
|
3094
Victoria's Secret
VSXY
$7.22B
| $1.43K | ﹤0.01% |
77
-51
| -40% | -$997 |
2021 Q3
15 quarters
|
|
3095
Frontdoor
FTDR
$5.39B
| $1.42K | ﹤0.01% |
24
+4
| +20% | +$201 |
2024 Q1
5 quarters
|
|
3096
Q2 Holdings
QTWO
$3.88B
| $1.4K | ﹤0.01% |
15
-40
| -73% | -$3.38K |
2024 Q3
3 quarters
|
|
3097
O-I Glass
OI
$910M
| $1.36K | ﹤0.01% |
92
+28
| +44% | +$358 |
2016 Q4
34 quarters
|
|
3098
Banco Bradesco
BBD
$45B
| $1.36K | ﹤0.01% |
439
-744
| -63% | -$1.96K |
2016 Q4
34 quarters
|
|
3099
Flywire
FLYW
$2.39B
| $1.36K | ﹤0.01% |
116
+70
| +152% | +$713 |
2025 Q1
1 quarter
|
|
3100
DELISTED
Vaxart
VXRT
| $1.36K | ﹤0.01% |
3,000
| – | – |
2019 Q3
23 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.